Corrigendum: Case Series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequalae of COVID (PASC)

Bruce K. Patterson; Ram Yogendra; Jose Guevara-Coto; Rodrigo A. Mora-Rodriguez; Eric Osgood; John Bream; Purvi Parikh; Mark Kreimer; Devon Jeffers; Cedric Rutland; Gary Kaplan; Michael Zgoda

doi:10.3389/fmed.2024.1375607

Back

Corrigendum: Case Series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequalae of COVID (PASC)

Journal article

Open access

Peer reviewed

Corrigendum: Case Series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequalae of COVID (PASC)

Bruce K. Patterson, Ram Yogendra, Jose Guevara-Coto, Rodrigo A. Mora-Rodriguez, Eric Osgood, John Bream, Purvi Parikh, Mark Kreimer, Devon Jeffers, Cedric Rutland, …

Frontiers in medicine, Vol.11

05/01/2024

DOI: https://doi.org/10.3389/fmed.2024.1375607

Abstract

CCR5 antagonist

fractalkine (CX3CR1)

long COVID

maraviroc

PASC

statins

Files and links (1)

url

https://doi.org/10.3389/fmed.2024.1375607View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: Corrigendum: Case Series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequalae of COVID (PASC)
Creators: Bruce K. Patterson - Incell Corporation
Ram Yogendra - Lahey Medical Center
Jose Guevara-Coto - Universidad de Costa Rica
Rodrigo A. Mora-Rodriguez - Universidad de Costa Rica
Eric Osgood - St Francis Medical Center
John Bream - Novant Health
Purvi Parikh - Tisch Hospital
Mark Kreimer - NewYork–Presbyterian Hospital
Devon Jeffers - Stamford Hospital
Cedric Rutland - Rutland Regional Medical Center
Gary Kaplan - Georgetown University Medical Center
Michael Zgoda - Creighton University
Publication Details: Frontiers in medicine, Vol.11
Publisher: Frontiers Media S.A
Identifiers: 991006086472302656
Academic Unit: Pulmonary and Critical Care
Language: English
Resource Type: Journal article